
Tempus AI’s Meteoric Rise: Signals a New Dawn in Healthcare Innovation
Tempus AI’s (TEM) stock value has soared by 40%, signalling strong investor interest and confidence in AI-driven healthcare solutions. The company reinforced its position through strategic acquisitions, notably Deep 6 AI and Ambry Genetics, enhancing its capabilities in clinical trial matching and